Hopefully the day traders will be back for the launch, I certainly will be and I'm unfazed if the coming weeks are lean,
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
TLS Telstra to boost phone plan prices despite inflation – and despite claiming they wouldn't 2 months ago